JP2024508045A5 - - Google Patents
Info
- Publication number
- JP2024508045A5 JP2024508045A5 JP2023571435A JP2023571435A JP2024508045A5 JP 2024508045 A5 JP2024508045 A5 JP 2024508045A5 JP 2023571435 A JP2023571435 A JP 2023571435A JP 2023571435 A JP2023571435 A JP 2023571435A JP 2024508045 A5 JP2024508045 A5 JP 2024508045A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- compound according
- group
- cancer
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163144287P | 2021-02-01 | 2021-02-01 | |
| US63/144,287 | 2021-02-01 | ||
| PCT/US2022/013725 WO2022164812A1 (en) | 2021-02-01 | 2022-01-25 | Phosphoinositide 3 kinase beta inhibitors and compositions and methods thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024508045A JP2024508045A (ja) | 2024-02-21 |
| JP2024508045A5 true JP2024508045A5 (cg-RX-API-DMAC7.html) | 2025-01-21 |
Family
ID=82654889
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023571435A Pending JP2024508045A (ja) | 2021-02-01 | 2022-01-25 | ホスホイノシチド3キナーゼベータ阻害剤ならびにそれらの組成物および方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240166617A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4284375A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024508045A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240016938A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117615763A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022214080A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3209581A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL304895A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022164812A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3217937A1 (en) | 2021-05-03 | 2022-11-10 | Erin Danielle ANDERSON | Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of disease |
| MX2023013987A (es) | 2021-05-27 | 2024-02-12 | Petra Pharma Corp | Inhibidores alostéricos de cromenona de la fosfoinosítido 3-quinasa (pi3k) para el tratamiento contra el cáncer. |
| TW202329930A (zh) | 2021-09-30 | 2023-08-01 | 美商佩特拉製藥公司 | 用於治療疾病之磷酸肌醇3-激酶(pi3k)之異位色烯酮抑制劑 |
| US20260130925A1 (en) * | 2022-10-14 | 2026-05-14 | Genesis Molecular Ai, Inc. | Methods for treating cancer |
| EP4602043A1 (en) * | 2022-10-14 | 2025-08-20 | Genesis Therapeutics, Inc. | 4h-pyrido[1,2-a]pyrimidin-4-one derivatives for treating cancer |
| EP4680612A1 (en) * | 2023-03-15 | 2026-01-21 | AN2 Therapeutics, Inc. | Chemical compounds |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE363471T1 (de) * | 2000-01-24 | 2007-06-15 | Astrazeneca Ab | Durch einen morpholinrest substituierte therapeutische verbindungen |
| EP1537102A4 (en) * | 2002-08-16 | 2010-12-08 | Astrazeneca Ab | INHIBITORS OF PHOSPHOINOSITIDE-3-KINASE BETA |
| WO2008148074A2 (en) * | 2007-05-24 | 2008-12-04 | Research Foundation Of State University Of New York | Inhibitors of mtor and methods of treatment using same |
| US8399460B2 (en) * | 2009-10-27 | 2013-03-19 | Astrazeneca Ab | Chromenone derivatives |
-
2022
- 2022-01-25 CN CN202280017243.9A patent/CN117615763A/zh active Pending
- 2022-01-25 EP EP22746472.4A patent/EP4284375A4/en active Pending
- 2022-01-25 WO PCT/US2022/013725 patent/WO2022164812A1/en not_active Ceased
- 2022-01-25 IL IL304895A patent/IL304895A/en unknown
- 2022-01-25 CA CA3209581A patent/CA3209581A1/en active Pending
- 2022-01-25 JP JP2023571435A patent/JP2024508045A/ja active Pending
- 2022-01-25 KR KR1020237029259A patent/KR20240016938A/ko active Pending
- 2022-01-25 US US18/273,634 patent/US20240166617A1/en active Pending
- 2022-01-25 AU AU2022214080A patent/AU2022214080A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI765451B (zh) | 作為erk抑制劑的螺環類化合物及其應用 | |
| US20220204507A1 (en) | Nitrogen-containing spiro derivative as ret inhibitor | |
| JP2025114615A (ja) | 治療薬としての細胞毒素のペプチドコンジュゲート | |
| US8026271B2 (en) | Formulations of indol-3-yl-2-oxoacetamide compounds | |
| CN101945876B (zh) | 对慢性疼痛疾病有活性的含氮双环化合物 | |
| US20240050401A1 (en) | Methods of treating social function disorders | |
| JP2004520285A5 (cg-RX-API-DMAC7.html) | ||
| JP2018524339A5 (cg-RX-API-DMAC7.html) | ||
| KR102866223B1 (ko) | 피롤로피리미딘 화합물 및 그 용도 | |
| US8704001B2 (en) | Deuterated 2-amino-3-hydroxypropanoic acid derivatives | |
| JP2022543666A5 (cg-RX-API-DMAC7.html) | ||
| RU2008119651A (ru) | Производные дикарбоновых кислот и их применение | |
| JP2020511547A5 (cg-RX-API-DMAC7.html) | ||
| JP2023528073A (ja) | Gpr65モジュレーターとしてのn-フェニルアミノカルボニル、ピリジノ-、ピリミジノ及びベンゾトロパン | |
| WO2022247757A1 (zh) | 氟取代的嘧啶并吡啶类化合物及其应用 | |
| RU2018103332A (ru) | Пиримидиновое соединение с конденсированными кольцами, его промежуточное соединение, способ получения, композиция и применение | |
| JP2024524312A (ja) | アリールシクロヘキシルアミン誘導体及び精神障害の処置におけるそれらの使用 | |
| JP2022529309A5 (cg-RX-API-DMAC7.html) | ||
| TW201231055A (en) | Novel medicament combinations for the treatment of respiratory diseases | |
| JP2024542881A5 (cg-RX-API-DMAC7.html) | ||
| US20190343827A1 (en) | Deuterated analogs of tariquidar | |
| KR101288791B1 (ko) | 베타 효능제의 흡입용 에어로졸 제형 | |
| WO2025227943A1 (zh) | 作为GSPTs/CK1α双靶降解剂的新型取代杂环类化合物 | |
| JP2023503672A (ja) | 縮合ピリジン環誘導体、その調製方法及びその医薬的応用 | |
| ES2677714T3 (es) | Nueva forma polimórfica de un agonista del adrenorreceptor beta-2 de acción prolongada |